Fig. 14From: De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learninga Experimental binding pose of peptidomimetic inhibitor 11a (PDB: 6LZE) and b docked pose of LaBECFar-11 on SARS-COV-2 Mpro. (PDB: 6W79). The amino acid residues are shown as beige sticks and the ligands as green sticksBack to article page